Gene · 55244
Papers1,509
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,509
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The OCT2/MATE1 Interaction Between Trifluridine, Metformin and Cimetidine: A Crossover Pharmacokinetic Study. | Clin Pharmacokinet | 2024 | 38951433 | PubTator, text mining | PubMed |
| Solute Carrier Transporters in Synovial Membrane and Hoffa's Pad of Patients with Rheumatoid Arthritis. | Arch Immunol Ther Exp (Warsz) | 2024 | 38932672 | PubTator, text mining | PubMed |
| Inhibitory effect of flavonoids on multidrug and toxin extrusion protein 1 function: Implications for food/herb-drug interaction and drug-induced kidney injury. | J Appl Toxicol | 2024 | 38760888 | PubTator, text mining | PubMed |
Survey of Pharmaceutical Industry's Best Practices around In Vitro Transporter Assessment and Implications for Drug Development: Considerations from the International Consortium for Innovation and Quality for Pharmaceutical Development Transporter Working Group. | Drug Metab Dispos | 2024 | 38697852 | PubTator, text mining | PubMed |
| Human ABC and SLC Transporters: The Culprit Responsible for Unspecific PSMA-617 Uptake? | Pharmaceuticals (Basel) | 2024 | 38675472 | PubTator, text mining | PubMed |
| How PBPK Can Help to Understand Old Drugs and Inform their Dosing in Elderly: Amantadine Case Study. | Clin Pharmacol Ther | 2024 | 38666589 | PubTator, text mining | PubMed |
| Use of a Double-Transfected System to Predict hOCT2/hMATE1-Mediated Renal Drug-Drug Interactions. | Drug Metab Dispos | 2024 | 38326034 | PubTator, text mining | PubMed |
| Interaction and Transport of Benzalkonium Chlorides by the Organic Cation and Multidrug and Toxin Extrusion Transporters. | Drug Metab Dispos | 2024 | 38307853 | PubTator, text mining | PubMed |
| Identification and characterization of an endogenous biomarker of the renal vectorial transport (OCT2-MATE1). | Biopharm Drug Dispos | 2024 | 38305087 | PubTator, text mining | PubMed |
| A Pilot Study To Assess the Suitability of Riboflavin As a Surrogate Marker of Breast Cancer Resistance Protein in Healthy Participants. | J Pharmacol Exp Ther | 2024 | 38296646 | PubTator, text mining | PubMed |
| Evaluation of the drug-drug interaction potential of brigatinib using a physiologically-based pharmacokinetic modeling approach. | CPT Pharmacometrics Syst Pharmacol | 2024 | 38288787 | PubTator, text mining | PubMed |
| Editorial: Transporters: a hitchhiker's guide to physiology, toxicology, and pharmacology-TransportDays 2022. | Front Pharmacol | 2024 | 38288437 | PubTator, text mining | PubMed |
| Tailoring Type II Diabetes Treatment: Investigating the Effect of 5-HTT Polymorphisms on HbA1c Levels after Metformin Initiation. | J Diabetes Res | 2024 | 38288388 | PubTator, text mining | PubMed |
| In Vitro Evaluation of Drug-Drug Interaction Potential of Epetraborole, a Novel Bacterial Leucyl-tRNA Synthetase Inhibitor. | Pharmaceuticals (Basel) | 2024 | 38256953 | PubTator, text mining | PubMed |
| New Antibiotics for the Treatment of Nosocomial Central Nervous System Infections. | Antibiotics (Basel) | 2024 | 38247617 | PubTator, text mining | PubMed |
| Genome-wide study investigating effector genes and polygenic prediction for kidney function in persons with ancestry from Africa and the Americas. | Cell Genom | 2024 | 38190104 | PubTator, text mining | PubMed |
| A Drug-Drug Interaction Study to Evaluate the Impact of Rimegepant on OCT2- and MATE1-Mediated Transport of Metformin in Healthy Participants. | Clin Pharmacol Drug Dev | 2024 | 38174905 | PubTator, text mining | PubMed |
| Mechanisms underlying therapeutic resistance of tyrosine kinase inhibitors in chronic myeloid leukemia. | Int J Biol Sci | 2024 | 38164178 | PubTator, text mining | PubMed |
| Maximum likelihood estimation of renal transporter ontogeny profiles for pediatric PBPK modeling. | CPT Pharmacometrics Syst Pharmacol | 2024 | 38156758 | PubTator, text mining | PubMed |
| Maribavir: Mechanism of action, clinical, and translational science. | Clin Transl Sci | 2024 | 38071422 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/55244/papers?page=5